NYT Editorial Stimulant Warning
It is no longer possible not to notice the lack of medical justification for current psychotropic drug prescribing practices.
-
-
ADHD Drug Risks: Cardiovascular and Cerebrovascular Problems
"This is out-of-control use of drugs that have profound cardiovascular consequences. We have got a potential public health crisis. I think patients and families need to be made aware of these concerns."
-
Safety of Newborn infants Threatened by Rx antidepressants during pregnancy
"During a hastily called press conference yesterday,” the FDA announced that it is considering ADDITIONAL warnings on the labels of SSRI drugs—Prozac, Paxil, Zoloft, et al.
-
Which is it—51 or 186 deaths linked to ADHD drugs?
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way:
-
Sham Peer Review
"Sham peer review," in medicine is not "only" affecting the integrity of
medical journals and the scientific literature, -
Israeli Study: One in 3 infants Suffer SSRI Withdrawal
It is astonishing how untrustworthy loosely given advice about the safety of SSRI antidepressants by medical professionals and academic institutions.
-
Weighing the Benefits & Risks of SSRI Antidepressants for Youth
Parents, physicians and the public attempting to make sense of the controversy about antidepressants are torn between unproven claims and counter-claims about the drugs’ benefits and risks.
-
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
-
Brain Images–What Do They Mean?
Benedict Carey of The New York Times reports with a degree of healthy skepticism about the latest scientific hoopla: Neuroscientists’ infatuation with brain imaging techniques.
-
When Trust in Doctors Erodes
"Soon, intuition and the personal experience of friends and family may seem as trustworthy as advice from a doctor in diagnosing an illness or judging a treatment."
-
Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost."
-
Antipsychotic Drugs are Killing patients_Brit J Psychiatry
A major 17-year follow up study published in the British Journal of Psychiatry [1] found a 2.84 times (95% CI 2.06–3.90) increased risk of mortality in people with schizophrenia compared to those not so diagnosed, and with each addition of a neuroleptic (antipsychotic) drug, the risk increased another 2.50.